Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Sep;176(9):eL230228.
doi: 10.7326/L23-0228.

Prevalence and Management of Obesity in U.S. Adults With Type 1 Diabetes

Affiliations
Comment

Prevalence and Management of Obesity in U.S. Adults With Type 1 Diabetes

Michael Fang et al. Ann Intern Med. 2023 Sep.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M22-3078.

Comment on

References

    1. Wallace AS, Chang AR, Shin JI, et al. Obesity and chronic kidney disease in US adults with type 1 and type 2 diabetes mellitus. J Clin Endocrinol Metab. 2022;107:1247–1256. doi:10.1210/clinem/dgab927 - DOI - PMC - PubMed
    1. Danne T, Garg S, Peters AL, et al. International consensus on risk management of diabetic ketoacidosis in patients with type 1 diabetes treated with sodium-glucose cotransporter (SGLT) inhibitors. Diabetes Care. 2019;42:1147–1154. doi:10.2337/dc18-2316 - DOI - PMC - PubMed
    1. Ahrén B, Hirsch IB, Pieber TR, et al.; ADJUNCT TWO Investigators. Efficacy and safety of liraglutide added to capped insulin treatment in subjects with type 1 diabetes: the ADJUNCT TWO randomized trial. Diabetes Care. 2016;39:1693–701. doi:10.2337/dc16-0690 - DOI - PubMed
    1. Holt RIG, DeVries JH, Hess-Fischl A, et al. The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2021;44:2589–2625. doi:10.2337/dci21-0043 - DOI - PubMed
    1. Taylor SI. The high cost of diabetes drugs: disparate impact on the most vulnerable patients. Diabetes Care. 2020;43:2330–2332. doi:10.2337/dci20-0039 - DOI - PMC - PubMed